• Dova Pharmaceuticals: 3Q Earnings Snapshot

    DURHAM, N.C. (AP) _ Dova Pharmaceuticals Inc. (DOVA) on Thursday reported a loss of $19.5 million in its third quarter.

    On a per-share basis, the Durham, North Carolina-based company said it had a loss of 69 cents.

    The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.

    The pharmaceutical company posted revenue of $2.9 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $2.7 million.

    Dova Pharmaceuticals shares have fallen 33 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.30, a drop of 20 percent in the last 12 months.


    This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DOVA at https://www.zacks.com/ap/DOVA

    Next Up: